Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeBrandName |
gptkb:Vyzulta
|
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:Japan
gptkb:United_States |
| gptkbp:ATCCode |
S01EE05
|
| gptkbp:brand |
gptkb:latanoprostene_bunod
|
| gptkbp:form |
eye drops
|
| gptkbp:genericName |
gptkb:latanoprostene_bunod
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vesneo
|
| gptkbp:indication |
ocular hypertension
open-angle glaucoma |
| gptkbp:manufacturer |
gptkb:Bausch_+_Lomb
|
| gptkbp:mechanismOfAction |
prostaglandin analog
nitric oxide donor |
| gptkbp:routeOfAdministration |
ophthalmic
|
| gptkbp:bfsParent |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:bfsLayer |
6
|